These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30309370)

  • 1. Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.
    Bessey A; Chilcott JB; Leaviss J; Sutton A
    Orphanet J Rare Dis; 2018 Oct; 13(1):179. PubMed ID: 30309370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted metabolomics revealed changes in phospholipids during the development of neuroinflammation in Abcd1
    Kettwig M; Klemp H; Nessler S; Streit F; Krätzner R; Rosewich H; Gärtner J
    J Inherit Metab Dis; 2021 Sep; 44(5):1174-1185. PubMed ID: 33855724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease - A population-based study.
    Sevin C; Hatteb S; Clément A; Bignami F; Chillotti L; Bugnard F; Bénard S; Boespflug-Tanguy O
    Orphanet J Rare Dis; 2023 Aug; 18(1):238. PubMed ID: 37563635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines.
    Mallack EJ; Turk BR; Yan H; Price C; Demetres M; Moser AB; Becker C; Hollandsworth K; Adang L; Vanderver A; Van Haren K; Ruzhnikov M; Kurtzberg J; Maegawa G; Orchard PJ; Lund TC; Raymond GV; Regelmann M; Orsini JJ; Seeger E; Kemp S; Eichler F; Fatemi A
    J Inherit Metab Dis; 2021 May; 44(3):728-739. PubMed ID: 33373467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
    Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
    Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
    Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
    Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
    Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
    JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
    Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
    Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method.
    Hubbard WC; Moser AB; Liu AC; Jones RO; Steinberg SJ; Lorey F; Panny SR; Vogt RF; Macaya D; Turgeon CT; Tortorelli S; Raymond GV
    Mol Genet Metab; 2009 Jul; 97(3):212-20. PubMed ID: 19423374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy.
    Wiens K; Berry SA; Choi H; Gaviglio A; Gupta A; Hietala A; Kenney-Jung D; Lund T; Miller W; Pierpont EI; Raymond G; Winslow H; Zierhut HA; Orchard PJ
    Am J Med Genet A; 2019 Jul; 179(7):1205-1213. PubMed ID: 31074578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-specific newborn screening for X-linked adrenoleukodystrophy.
    Albersen M; van der Beek SL; Dijkstra IME; Alders M; Barendsen RW; Bliek J; Boelen A; Ebberink MS; Ferdinandusse S; Goorden SMI; Heijboer AC; Jansen M; Jaspers YRJ; Metgod I; Salomons GS; Vaz FM; Verschoof-Puite RK; Visser WF; Dekkers E; Engelen M; Kemp S
    J Inherit Metab Dis; 2023 Jan; 46(1):116-128. PubMed ID: 36256460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
    Theda C; Gibbons K; Defor TE; Donohue PK; Golden WC; Kline AD; Gulamali-Majid F; Panny SR; Hubbard WC; Jones RO; Liu AK; Moser AB; Raymond GV
    Mol Genet Metab; 2014 Jan; 111(1):55-7. PubMed ID: 24268529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges.
    Baker CV; Cady Keller A; Lutz R; Eveans K; Baumert K; DiPerna JC; Rizzo WB
    Int J Neonatal Screen; 2022 Apr; 8(2):. PubMed ID: 35645283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.
    Hamers FF; Rumeau-Pichon C
    BMC Pediatr; 2012 Jun; 12():60. PubMed ID: 22681855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
    Sandlers Y; Moser AB; Hubbard WC; Kratz LE; Jones RO; Raymond GV
    Mol Genet Metab; 2012 Mar; 105(3):416-20. PubMed ID: 22197596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
    Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
    PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
    Hong X; Kumar AB; Ronald Scott C; Gelb MH
    Mol Genet Metab; 2018 Jun; 124(2):101-108. PubMed ID: 29680633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
    Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW
    Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for adrenoleukodystrophy: implications for therapy.
    Raymond GV; Jones RO; Moser AB
    Mol Diagn Ther; 2007; 11(6):381-4. PubMed ID: 18078355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
    Tian GL; Xu F; Jiang K; Wang YM; Ji W; Zhuang YP
    Clin Chim Acta; 2020 Apr; 503():157-162. PubMed ID: 31978407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.